{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:58Z","timestamp":1707524278370},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,21]]},"DOI":"10.7759\/cureus.16534","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T14:19:46Z","timestamp":1626877186000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathological and Immunohistochemical Profile of Mantle Cell Lymphoma: An Institutional Experience"],"prefix":"10.7759","author":[{"given":"Pritinanda","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somanath","family":"Padhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavithra","family":"Ayyanar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swagatika","family":"Samal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saroj","family":"Das Majumdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukund","family":"Sable","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.42503","article-title":"A clinicopathologic study of mantle cell lymphoma in a single center study in India","volume":"51","author":"Gujral S","year":"2008","unstructured":"Gujral S, Agarwal A, Gota V, et al.. A clinicopathologic study of mantle cell lymphoma in a single center study in India. Indian J Pathol Microbiol. 2008, 51:315-22. 10.4103\/0377-4929.42503","journal-title":"Indian J Pathol Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2011.03.006","article-title":"Histopathology of mantle cell lymphoma","volume":"48","author":"Klapper W","year":"2011","unstructured":"Klapper W. Histopathology of mantle cell lymphoma. Semin Hematol. 2011, 48:148-54. 10.1053\/j.seminhematol.2011.03.006","journal-title":"Semin Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2017-0368-OA","article-title":"Immunophenotypic variations in mantle cell lymphoma and their impact on clinical behavior and outcome","volume":"142","author":"Aqil B","year":"2018","unstructured":"Aqil B, Triska G, Frater J, et al.. Immunophenotypic variations in mantle cell lymphoma and their impact on clinical behavior and outcome. Arch Pathol Lab Med. 2018, 142:1268-1274. 10.5858\/arpa.2017-0368-OA","journal-title":"Arch Pathol Lab Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo E","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011, 117:5019-5032. 10.1182\/blood-2011-01-293050","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPV8LN5ENMZOVY","article-title":"Immunophenotypic variations in mantle cell lymphoma","volume":"132","author":"Gao J","year":"2009","unstructured":"Gao J, Peterson L, Nelson B, Goolsby C, Chen YH. Immunophenotypic variations in mantle cell lymphoma. Am J Clin Pathol. 2009, 132:699-706. 10.1309\/AJCPV8LN5ENMZOVY","journal-title":"Am J Clin Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.03060.x","article-title":"Mantle cell lymphoma with aberrant expression of CD10","volume":"53","author":"Zanetto U","year":"2008","unstructured":"Zanetto U, Dong H, Huang Y, et al.. Mantle cell lymphoma with aberrant expression of CD10. Histopathology. 2008, 53:20-29. 10.1111\/j.1365-2559.2008.03060.x","journal-title":"Histopathology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.03978.x","article-title":"Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas","volume":"59","author":"Tapia G","year":"2011","unstructured":"Tapia G, Lopez R, Mu\u00f1oz-M\u00e1rmol AM, et al.. Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas. Histopathology. 2011, 59:672-678. 10.1111\/j.1365-2559.2011.03978.x","journal-title":"Histopathology"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas","volume":"87","author":"Hernandez L","year":"1996","unstructured":"Hernandez L, Fest T, Cazorla M, et al.. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood. 1996, 87:3351-3359.","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.99","article-title":"Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype","volume":"28","author":"Ribera-Cortada I","year":"2015","unstructured":"Ribera-Cortada I, Martinez D, Amador V, et al.. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype. Mod Pathol. 2015, 28:1435-1447. 10.1038\/modpathol.2015.99","journal-title":"Mod Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000016069","article-title":"Regional variation in the distribution of subtypes of lymphoid neoplasms in India","volume":"43","author":"Naresh KN","year":"2002","unstructured":"Naresh KN, Agarwal B, Sangal BC, Basu DD, Kothari AS, Soman CS. Regional variation in the distribution of subtypes of lymphoid neoplasms in India. Leuk Lymphoma. 2002, 43:1939-1943. 10.1080\/1042819021000016069","journal-title":"Leuk Lymphoma"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2016.792","article-title":"Cutaneous involvement as a rare first sign of systemic mantle cell lymphoma: a case report and review of the literature","volume":"4","author":"Hrgovic I","year":"2016","unstructured":"Hrgovic I, Hartmann S, Steffen B, Vogl T, Kaufmann R, Meissner M. Cutaneous involvement as a rare first sign of systemic mantle cell lymphoma: a case report and review of the literature. Mol Clin Oncol. 2016, 4:728-732. 10.3892\/mco.2016.792","journal-title":"Mol Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.052621","article-title":"In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior","volume":"97","author":"Carvajal-Cuenca A","year":"2012","unstructured":"Carvajal-Cuenca A, Sua LF, Silva NM, et al.. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica. 2012, 97:270-278. 10.3324\/haematol.2011.052621","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.118680","article-title":"Nodal mantle cell lymphoma: a descriptive study from a tertiary care center in south India","volume":"56","author":"Roy A","year":"2013","unstructured":"Roy A, Kar R, Basu D. Nodal mantle cell lymphoma: a descriptive study from a tertiary care center in south India. Indian J Pathol Microbiol. 2013, 56:94-97. 10.4103\/0377-4929.118680","journal-title":"Indian J Pathol Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-189977","article-title":"Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era","volume":"117","author":"P\u00e9rez-Gal\u00e1n P","year":"2011","unstructured":"P\u00e9rez-Gal\u00e1n P, Dreyling M, Wiestner A. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood. 2011, 117:26-38. 10.1182\/blood-2010-04-189977","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos A","year":"2009","unstructured":"Mozos A, Royo C, Hartmann E, et al.. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009, 94:1555-1562. 10.3324\/haematol.2009.010264","journal-title":"Haematologica"},{"key":"ref16","article-title":"Mantle cell lymphoma and variants: a clinicopathological and immunohistochemical study","volume":"3","author":"Kwatra KS","year":"2016","unstructured":"Kwatra KS, Paul PA, Dhaliwal D, Calton N, John JM. Mantle cell lymphoma and variants: a clinicopathological and immunohistochemical study. Int J Sci Stud. 2016, 3:166-172.","journal-title":"Int J Sci Stud"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001278","article-title":"CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 patients","volume":"43","author":"Miao Y","year":"2019","unstructured":"Miao Y, Lin P, Saksena A, et al.. CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 patients. Am J Surg Pathol. 2019, 43:1052-1060. 10.1097\/PAS.0000000000001278","journal-title":"Am J Surg Pathol"},{"key":"ref18","article-title":"CD5-negative mantle cell lymphoma shows a less aggressive outcome and variable SOX11 staining","volume":"10","author":"Shih AR","year":"2017","unstructured":"Shih AR, Bledsoe JR, McKelvie P, Louissaint A, Harris NL, Zuckerberg L. CD5-negative mantle cell lymphoma shows a less aggressive outcome and variable SOX11 staining. J Hematopathol. 2017, 10:49-53.","journal-title":"J Hematopathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2019.04.010","article-title":"CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis","volume":"89","author":"Saksena A","year":"2019","unstructured":"Saksena A, Yin CC, Xu J, et al.. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis. Hum Pathol. 2019, 89:71-80. 10.1016\/j.humpath.2019.04.010","journal-title":"Hum Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001233","article-title":"SOX11-negative mantle cell lymphoma: clinicopathologic and prognostic features of 75 patients","volume":"43","author":"Xu J","year":"2019","unstructured":"Xu J, Wang L, Li J, et al.. SOX11-negative mantle cell lymphoma: clinicopathologic and prognostic features of 75 patients. Am J Surg Pathol. 2019, 43:710-716. 10.1097\/PAS.0000000000001233","journal-title":"Am J Surg Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-400580","article-title":"Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma","volume":"119","author":"Nygren L","year":"2012","unstructured":"Nygren L, Baumgartner Wennerholm S, Klimkowska M, Christensson B, Kimby E, Sander B. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood. 2012, 119:4215-4223. 10.1182\/blood-2011-12-400580","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fern\u00e0ndez V","year":"2010","unstructured":"Fern\u00e0ndez V, Salamero O, Espinet B, et al.. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010, 70:1408-1418. 10.1158\/0008-5472.CAN-09-3419","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e3181bb9edf","article-title":"BCL6, MUM1, and CD10 expression in mantle cell lymphoma","volume":"18","author":"Gualco G","year":"2010","unstructured":"Gualco G, Weiss LM, Harrington WJ Jr, Bacchi CE. BCL6, MUM1, and CD10 expression in mantle cell lymphoma. Appl Immunohistochem Mol Morphol. 2010, 18:103-108. 10.1097\/PAI.0b013e3181bb9edf","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318166f46a","article-title":"Expression of the interferon regulatory factor 8\/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker","volume":"32","author":"Martinez A","year":"2008","unstructured":"Martinez A, Pittaluga S, Rudelius M, et al.. Expression of the interferon regulatory factor 8\/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker. Am J Surg Pathol. 2008, 32:1190-1200. 10.1097\/PAS.0b013e318166f46a","journal-title":"Am J Surg Pathol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10891","article-title":"Increased MDM2 expression is associated with inferior survival in mantle-cell lymphoma, but not related to the MDM2 SNP309","volume":"92","author":"Hartmann E","year":"2007","unstructured":"Hartmann E, Fern\u00e0ndez V, Stoecklein H, Hern\u00e1ndez L, Campo E, Rosenwald A. Increased MDM2 expression is associated with inferior survival in mantle-cell lymphoma, but not related to the MDM2 SNP309. Haematologica. 2007, 92:574-575. 10.3324\/haematol.10891","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/pin.13038","article-title":"Mantle cell lymphoma with EBV-positive Hodgkin and Reed-Sternberg-like cells in a patient after autologous PBSCT: phenotypically distinct but genetically related tumors","volume":"71","author":"Kanai R","year":"2021","unstructured":"Kanai R, Miyagawa-Hayashino A, Shishido-Hara Y, et al.. Mantle cell lymphoma with EBV-positive Hodgkin and Reed-Sternberg-like cells in a patient after autologous PBSCT: phenotypically distinct but genetically related tumors. Pathol Int. 2021, 71:96-101. 10.1111\/pin.13038","journal-title":"Pathol Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61368-clinicopathological-and-immunohistochemical-profile-of-mantle-cell-lymphoma-an-institutional-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:52Z","timestamp":1707507172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61368-clinicopathological-and-immunohistochemical-profile-of-mantle-cell-lymphoma-an-institutional-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.16534","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,21]]}}}